2022-08-05T09:46:26-05:00 2021-09-30 366055558 GRANT THORNTON LLP 100 E WISCONSIN AVE MILWAUKEE WI 53202 990 2020-10-01 840865803 NATIONAL MARROW DONOR PROGRAM NATI 7634065800 500 N 5TH ST MINNEAPOLIS MN 554011206 KRISTA DUSIL CFO 7634064275 2022-08-04 1 KRISTA DUSIL 999009999 MICHELLE L WEBER P00556798 4142898200 2022-08-04 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z BE THE MATCH KRISTA DUSIL 500 N 5TH ST MINNEAPOLIS MN 554011206 448910717 0 X WWW.BETHEMATCH.ORG X 1981 CO WE SAVE LIVES THROUGH CELLULAR THERAPY 16 16 1234 1874 97611 83992 50072983 51162924 385698701 388404186 7032444 5425010 193253 97611 442997381 445089731 8777583 8085919 0 0 131574222 144155513 0 0 0 305095864 313304662 445447669 465546094 -2450288 -20456363 371669572 364758095 136369143 139469682 235300429 225288413 X THE MISSION OF NATIONAL MARROW DONOR PROGRAM (NMDP), ALSO KNOWN AS BE THE MATCH (BTM), IS TO SAVE LIVES THROUGH CELLULAR THERAPY 0 0 265186576 0 371514387 TRANSPLANT - IN 1987, THE FOUNDERS OF NATIONAL MARROW DONOR PROGRAM (NMDP) MADE A COMMITMENT TO INCREASE ACCESS TO TRANSPLANTS AND TO FIND PEOPLE WILLING TO DONATE AND SUPPORT RESEARCH TO EXTEND AND IMPROVE LIVES. NMDP'S MISSION STATEMENT - "WE SAVE LIVES THROUGH CELLULAR THERAPY" - CAPTURES AND COMMUNICATES THE REASON FOR NMDP'S EXISTENCE. EACH YEAR, NMDP INCURS PROGRAM MEDICAL EXPENSES RELATED TO MATCHING UNRELATED DONORS WITH PATIENTS. IN FY2021, MORE THAN 15,400 U.S. AND INTERNATIONAL SEARCHES OF THE BE THE MATCH REGISTRY WERE CONDUCTED ON BEHALF OF PATIENTS SEEKING A MATCHING DONOR OR CORD BLOOD UNIT.6,649 PATIENTS WENT ON TO RECEIVE A TRANSPLANT. SINCE BEGINNING OPERATIONS, NMDP HAS FACILITATED MORE THAN (CONTINUED ON SCHEDULE O) 111,500 MARROW AND CORD BLOOD TRANSPLANTS FOR PATIENTS. 51208135 0 0 RECRUITMENT - THE BE THE MATCH REGISTRY PROVIDES THE MOST DIVERSE LISTING OF POTENTIAL DONORS AND CORD BLOOD UNITS IN THE WORLD, WITH ACCESS TO 39 MILLION POTENTIAL DONORS AND 806,000 CORD BLOOD UNITS WORLDWIDE. IN FY2021, OVER 250,000 NEW POTENTIAL DONORS WERE ADDED TO THE BE THE MATCH REGISTRY. ALTHOUGH THERE ARE MILLIONS ON THE REGISTRY, PATIENTS SOMETIMES STILL CANNOT FIND A MATCH. THIS IS DUE IN PART TO THE PATIENT'S ETHNIC BACKGROUND. ON AVERAGE, A PATIENT'S LIKELIHOOD OF FINDING A MATCH ON THE BE THE MATCH REGISTRY RANGES FROM 29% TO 79% DEPENDING ON THE ETHNIC BACKGROUND. SOME ETHNIC GROUPS HAVE MORE COMPLEX TISSUE TYPES THAN OTHERS, SO A PERSON'S BEST CHANCE OF FINDING A DONOR IS WITH SOMEONE OF THE SAME ETHNIC BACKGROUND. THE IMPORTANCE OF INCREASING DIVERSITY ON THE REGISTRY IS AN (CONTINUED ON SCHEDULE O) ORGANIZATION GOAL AND PRIORITY AT BE THE MATCH.BE THE MATCH MEXICO WAS STARTED IN 2017. WITH THE GOAL OF REACHING MORE PATIENTS AND INCREASING DIVERSITY ON THE REGISTRY, WORK HAS BEGUN TO CREATE A NETWORK OF DONOR CENTERS AND FUNDRAISING PARTNERS IN MEXICO. 48316585 326815 16814205 RESEARCH - RESEARCH INNOVATIONS ARE CRITICAL TO EXPANDING TREATMENT TO MORE PATIENTS AND IMPROVING OUTCOMES. EACH YEAR, BTMF IS PROUD TO INVEST IN RESEARCH THROUGH:ANTHONY NOLAN TRUST: PROVIDE SUPPORT TO THE ANTHONY NOLAN RESEARCH INSTITUTE TO CONTINUE DEVELOPMENT AND MAINTENANCE OF AN HLA CLASS I AND II SEQUENCE DATABASE AND PROVISION OF HLA CLASS I AND II SEQUENCE INFORMATION.BE THE MATCH'S CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH (CIBMTR) - A PARTNERSHIP WITH THE MEDICAL COLLEGE OF WISCONSIN - IS THE LEADING HUB FOR TRANSPLANT AND CELL (CONTINUED ON SCHEDULE O) THERAPY RESEARCH. BTMF HELPS TO FUND INNOVATIVE RESEARCH STUDIES LED AND MANAGED BY THE CIBMTR. 23040259 7759104 75594 OTHER PROGRAM SERVICESPUBLIC AWARENESS - NMDP WORKS WITH PATIENT FAMILIES, FAITH COMMUNITIES, CORPORATIONS, COLLEGES AND UNIVERSITIES, AND OTHER ORGANIZATIONS TO RAISE AWARENESS ABOUT THE OPPORTUNITY TO GIVE PATIENTS HOPE BY JOINING THE REGISTRY, MAKING A GIFT THROUGH BE THE MATCH FOUNDATION (BTMF), ANDVOLUNTEERING. IN ADDITION, NMDP IS A LEADER IN PROVIDING HEALTH CARE PROFESSIONALS WITH THE EDUCATION, RESOURCES AND SERVICES THEY NEED TO PROVIDE THE BEST CARE FOR TRANSPLANT PATIENTS. 23040259 7759104 75594 387751555 1 1 0 1 0 0 0 0 0 0 1 0 1 0 1 1 0 1 0 1 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 0 0 1 1366 0 1 1234 1 1 1 1 CJ MX 0 0 0 0 0 0 0 0 1 0 X 16 16 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AR CA FL GA HI IL KS KY MD MA MI MN MS NH NJ NM NY NC OR PA RI SC TN UT VA WV WI X KRISTA DUSIL 7634064275 500 N 5TH ST MINNEAPOLIS MN 554011206 X AMY RONNEBERG CHIEF EXECUTIVE OFFICER 48.00 2.00 X 1109940 0 28461 C RANDAL MILLS CHIEF EXECUTIVE OFFICER-THRU 2/2020 50.00 0.00 X 754411 0 3307 STEVEN DEVINE CHIEF MEDICAL OFFICER 50.00 0.00 X 659212 0 52574 BRIAN LINDBERG CHIEF LEGAL & POLICY OFF/GEN COUNSEL 49.00 1.00 X 597433 0 54905 MICHAEL MCCULLOUGH CHIEF INFORMATION OFFICER 47.00 3.00 X 597535 0 53909 JOHN MILLER VP, MEDICAL & QUALITY SERVICES 50.00 0.00 X 552339 0 37655 JULIE SMOLICH SVP, PROVIDER SERVICES 49.00 1.00 X 488030 0 54006 JAMIE MARGOLIS SVP, DONOR SERVICES 49.50 0.50 X 441409 0 37796 ERICA JENSEN SVP, REGISTRY GROWTH & DEVELOPMENT 49.00 1.00 X 420878 0 29361 PATRICK REINKEN VP, LEGAL AFFAIRS & RISK MGMT/AGC 49.00 1.00 X 388332 0 53739 REBECCA JORGENSON SVP, INNOVATION - THRU 3/2020 49.00 1.00 X 391810 0 3050 GINA GRAVES ACT. CFO-THRU 4/21; VP FIN-THRU 8/21 49.00 1.00 X 309840 0 40118 INDIA HOOK-BARNARD SVP, PATIENT OUTCOME & EXP-THRU 4/20 49.00 1.00 X 324538 0 6541 DENNIS CONFER CMO EMERITUS - THRU 9/2021 49.00 1.00 X 105399 0 31307 DAVID PORTER IMMEDIATE PAST CHAIR 1.00 0.00 X 900 0 0 KRISTA DUSIL CHIEF FINANCIAL OFFICER-AS OF 4/2021 49.00 1.00 X 0 0 0 ROBERT SOIFFER CHAIR 1.00 0.00 X 0 0 0 MIGUEL-ANGEL PERALES VICE CHAIR 1.00 0.00 X 0 0 0 MELINDA CALTABIANO SECRETARY 1.00 0.00 X 0 0 0 LYNN ABRAHAMSEN DIRECTOR 1.00 0.00 X 0 0 0 JUDITH GASSON DIRECTOR 1.00 0.00 X 0 0 0 HOPE GUIDRY-GROVES DIRECTOR - THRU 5/2021 1.00 0.00 X 0 0 0 URI HERZBERG DIRECTOR 1.00 0.00 X 0 0 0 KRISHNA KOMANDURI DIRECTOR 1.00 0.00 X 0 0 0 GARHENG KONG DIRECTOR 1.00 0.00 X 0 0 0 MICHAEL LANG DIRECTOR 1.00 0.00 X 0 0 0 RAVYN MILLER DIRECTOR 1.00 0.00 X 0 0 0 BRIAN REITHEL DIRECTOR 1.00 0.00 X 0 0 0 HARPREET SANDHU DIRECTOR 1.00 0.00 X 0 0 0 DAVID SCHUBERT DIRECTOR 1.00 0.00 X 0 0 0 LAURIE STRONGIN DIRECTOR 1.00 0.00 X 0 0 0 ABIGAIL WEST DIRECTOR 1.00 0.00 X 0 0 0 7142006 0 486729 370 1 1 0 THE EMMES CORPORATION 401 N WASHINGTON STREET SUITE 700 ROCKVILLE MD 20850 RESEARCH DATA COLLECTION 9603883 CICERON 126 NORTH THIRD STREET SUITE 200 MINNEAPOLIS MN 55401 MARKETING AGENCY 6107784 COHERENT SOLUTIONS INC 1600 UTICA AVE S SUITE 120 MINNEAPOLIS MN 55416 IT SERVICES 3509129 HOLLSTADT & ASSOCIATES INC 1333 NORTHLAND DR STE 220 MENDOTA HEIGHTS MN 55120 BUSINESS CONSULTING 2930578 EPLUS TECHNOLOGY 13595 DULLES TECHNOLOGY DRIVE HERNDON VA 20171 IT SERVICES 2446733 123 2524739 47561440 1076745 264772 51162924 SEARCH/PROCUREMENT REVENUE 621990 388404186 388404186 388404186 2680739 2680739 317701 220090 97611 97611 97611 6345167 3600896 2744271 2744271 2744271 445089731 388404186 97611 5425010 7750307 7750307 335612 335612 4418647 4418647 101795 101795 112692145 84101566 28590579 5640618 4126455 1514163 12634096 8244561 4389535 8668212 6368988 2299224 865602 865602 123092 123092 432702 432702 66906 66906 24132581 19883651 4248930 12988672 11171392 1817280 3023406 2198986 824420 36521442 25822599 10698843 4071411 640861 3430550 378260 269746 108514 887432 206554 680878 2091261 2091261 16725641 7310529 9415112 1184527 297442 887085 MEDICAL SERVICE EXPENSE 181166669 181166669 DONOR RECRUITMENT SVCS 16291929 16291929 FORMS COMPL & RESEARCH 10675671 10675671 UBI TAX EXPENSE 44831 44831 1632627 888037 744590 465546094 387751555 77794539 0 74918269 42766519 14557 38 9453817 9188558 52273042 58243448 0 0 0 0 0 0 92003 92003 8537786 9492609 154276009 65094878 90149358 89181131 113179139 124655944 0 0 15004373 22689894 0 0 8047228 8447951 371669572 364758095 81087182 86736891 0 0 2747230 2578300 0 0 0 0 0 0 0 0 0 0 52534731 50154491 136369143 139469682 X 235300429 225288413 0 0 235300429 225288413 371669572 364758095 -20456363 10444347 0 X 0 1 X 1 1 1 X 53550922 53186777 55288081 50072983 51162924 263261687 335484500 360320448 386677912 385698701 388404186 1856585747 389035422 413507225 441965993 435771684 439567110 2119847434 0 2785853 2785853 2785853 2785853 2117061581 2199733 2608886 3257641 3232070 2680739 13979069 2199733 2608886 3257641 3232070 2680739 13979069 28200 65221 85122 83992 262535 391235155 416144311 445288855 439088876 442331841 2134089038 0.99200 0.99360 0.00660 0.00630 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 13348 13348 433830 433830 447178 447178 465098916 478632462 465546094 479079640 1000000 1000000 250000 250000 0 0 0 0 1000000 1000000 1000000 1000000 4000000 6000000 467528 751146 329683 447178 1995535 250000 250000 250000 250000 1000000 1500000 235 13348 13583 SCHEDULE C, PART II-A, COLUMN A, AFFILIATED ORGANIZATIONS ORGANIZATION NAME: NATIONAL MARROW DONOR PROGRAM ADDRESS: 500 N 5TH ST. MINNEAPOLIS, MN 55401 EIN: 84-0865803 GRASSROOTS LOBBYING AMOUNT: 13,348. DIRECT LOBBYING AMOUNT: 433,830. TOTAL LOBBYING EXPENDITURES: 447,178. OTHER EXEMPT PURPOSE EXPENDITURES: 465,098,916. TOTAL EXEMPT PURPOSE EXPENDITURES: 465,546,094. LOBBYING NONTAXABLE AMOUNT: 1,000,000. GRASSROOTS NONTAXABLE AMOUNT: 250,000. TOTAL GRASSROOTS LESS NONTAXABLE AMOUNT: TOTAL EXPENDITURES LESS NONTAXABLE AMOUNT: SHARE OF EXCESS LOBBYING EXPENDITURES: SCHEDULE C, PART II-A, COLUMN B, AFFILIATED ORGANIZATIONS ORGANIZATION NAME: BE THE MATCH FOUNDATION ADDRESS: 500 N 5TH ST. MINNEAPOLIS, MN 55401 EIN: 41-1704734 GRASSROOTS LOBBYING AMOUNT: DIRECT LOBBYING AMOUNT: TOTAL LOBBYING EXPENDITURES: OTHER EXEMPT PURPOSE EXPENDITURES: 13,533,546. TOTAL EXEMPT PURPOSE EXPENDITURES: 13,533,546. LOBBYING NONTAXABLE AMOUNT: GRASSROOTS NONTAXABLE AMOUNT: TOTAL GRASSROOTS LESS NONTAXABLE AMOUNT: TOTAL EXPENDITURES LESS NONTAXABLE AMOUNT: SHARE OF EXCESS LOBBYING EXPENDITURES: 60208870 23285198 36923672 6639009 2311750 4327259 21654021 11704034 9949987 65774109 27793896 37980213 89181131 PRI - FOREIGN SUBSIDIARIES 8384541 C PRI - TMUNITY 6750000 C PRI - MAGENTA THERAPEUTICS 4321477 C PRI - BE THE MATCH AUXILIARY SERVICES 3233876 C 22689894 LONG TERM CAPITAL LEASE 44418123 DEFERRED COMPENSATION PAYABLE 5736368 50154491 X PART X, LINE 2: ORGANIZATION'S LIABILITY FOR UNCERTAIN TAX POSITIONS UNDER ASC 740 THE INTERNAL REVENUE SERVICE HAS DETERMINED THAT THE PROGRAM AND BTMF ARE TAX-EXEMPT ORGANIZATIONS UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE NOT-FOR-PROFIT STATUS OF THE PROGRAM AND BTMF ARE CONSIDERED TAX POSITIONS UNDER FASB ASC 740, INCOME TAXES. THE ORGANIZATION FOLLOWS THE ACCOUNTING STANDARDS FOR CONTINGENCIES IN EVALUATING UNCERTAIN TAX POSITIONS. THIS GUIDANCE PRESCRIBES RECOGNITION THRESHOLD PRINCIPLES FOR THE FINANCIAL STATEMENT RECOGNITION OF TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN ON A TAX RETURN THAT ARE NOT CERTAIN TO BE REALIZED. NO LIABILITY HAS BEEN RECOGNIZED BY THE ORGANIZATION FOR UNCERTAIN TAX POSITIONS AS OF SEPTEMBER 30, 2021 OR 2020. THE ORGANIZATION'S TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL AND STATE AUTHORITIES. BTMCS IS TREATED AS A DISREGARDED ENTITY FOR INCOME TAX REPORTING PURPOSES. AS SUCH, BTMCS'S INCOME, LOSSES AND CREDITS ARE INCLUDED IN THE TAX RETURN OF ITS SOLE MEMBER AND PARENT, NMDP. BTMAS IS A REGARDED ENTITY FOR TAX PURPOSES AND FILES A SEPARATE TAX RETURN. CLEAR IS AN EXEMPTED COMPANY OPERATING SUBJECT TO THE COMPANIES LAW (REVISED) OF CAYMAN ISLANDS AND IS INCLUDED IN THE TAX RETURN OF NMDP. BTMM IS TREATED AS A FOREIGN CORPORATION FOR U.S INCOME TAX REPORTING PURPOSES. BTMM FILES A SEPARATE TAX RETURN IN MEXICO. 1 CENTRAL AMERICA AND THE CARIBBEAN 1 0 PROGRAM SERVICES CAPTIVE INSURANCE 1664294 CENTRAL AMERICA AND THE CARIBBEAN 1 0 MAINTAINING OFFICES CAPTIVE INSURANCE 163389 CENTRAL AMERICA AND THE CARIBBEAN 1 0 INVESTMENTS CAPTIVE INSURANCE 13088 CENTRAL AMERICA AND THE CARIBBEAN 1 0 PROGRAM SERVICES MEDICAL 2389515 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES MEDICAL 2795247 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES MEDICAL 36950729 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING RESEARCH 326815 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES MEDICAL 3864398 NORTH AMERICA 1 0 PROGRAM SERVICES MEDICAL 895000 NORTH AMERICA 1 0 INVESTMENTS MEDICAL 2764042 NORTH AMERICA 1 0 PROGRAM SERVICES MEDICAL 5474928 RUSSIA AND NEIGHBORING STATES 0 0 PROGRAM SERVICES MEDICAL 8416 SOUTH AMERICA 0 0 PROGRAM SERVICES MEDICAL 2403249 SOUTH ASIA 0 0 PROGRAM SERVICES MEDICAL 181437 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES MEDICAL 259877 2 0 0 0 2 0 48167475 11986949 60154424 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 326815 WIRE FMV EUROPE (INCLUDING ICELAND & GREENLAND) CONFERENCE SPONSOR 8797 WIRE FMV 2 0 1 0 1 0 0 1 PART III ACCOUNTING METHOD: SCHEDULE F, PART I, LINE 2: PROCEDURE FOR MONITORING USE OF GRANT FUNDS OUTSIDE U.S. INTERNATIONAL TRANSPLANT CENTERS THROUGHOUT THE WORLD WORK IN AFFILIATION WITH NMDP TO FIND DONORS FOR THE PATIENTS IN NEED. PROGRESS REPORTS ARE SUBMITTED BY RESEARCH SCIENTISTS FOR NMDP'S REVIEW. IF THE PROGRESS IS SATISFACTORY, FUNDS ARE DISTRIBUTED TO THE SCIENTISTS. IF NO PROGRESS REPORT IS SUBMITTED OR THE PROGRESS IS DEEMED UNSATISFACTORY, NO FUNDS WILL BE DISTRIBUTED. SCHEDULE F, PART I, LINE 3 TOTAL EXPENDITURES BY REGION THE TOTAL EXPENDITURES BY REGION CALCULATED AMOUNT EQUALS THE CHECKS THAT ACCOUNTS PAYABLE CUT DURING FY2021. 1 CORD BLOOD ASSOCIATION 211 GARFIELD STREET GENEVA IL 60134 472512300 501(C)(3) 19000 CONFERENCE SPONSOR PARENTS GUIDE TO CORD BLOOD FOUNDATION 23110 GEORGIA AVE BROOKEVILLE MD 20833 208939848 501(C)(3) 5000 CONFERENCE SPONSOR BE THE MATCH FOUNDATION 500 N 5TH STREET MINNEAPOLIS MN 55401 411704734 501(C)(3) 7715917 FOUNDATION OPERATIONS 3 0 PART I, LINE 2: PROCEDURE FOR MONITORING THE USE OF GRANT FUNDS INSIDE THE U.S. BEFORE ANY CHECK IS CUT FOR EVENT OR OTHER SPONSORSHIP, THE DOCUMENTATION AROUND WHAT THE EXPENDITURE IS FOR IS REVIEWED AND ROUTED THROUGH OUR ORACLE PROCUREMENT MODULE APPROVALS FOLLOWING OUR ORGANIZATION'S CHART OF AUTHORITY. X 1 1 X X X X X 1 1 0 0 0 0 0 1 0 AMY RONNEBERG CHIEF EXECUTIVE OFFICER 646059 0 358924 0 104957 0 25185 0 3276 0 1138401 0 0 0 C RANDAL MILLS CHIEF EXECUTIVE OFFICER-THRU 2/2020 100063 0 4999 0 649349 0 0 0 3307 0 757718 0 0 0 STEVEN DEVINE CHIEF MEDICAL OFFICER 422833 0 161553 0 74826 0 25185 0 27389 0 711786 0 0 0 BRIAN LINDBERG CHIEF LEGAL & POLICY OFF/GEN COUNSEL 383383 0 147306 0 66744 0 25185 0 29720 0 652338 0 0 0 MICHAEL MCCULLOUGH CHIEF INFORMATION OFFICER 351811 0 186807 0 58917 0 25185 0 28724 0 651444 0 0 0 JOHN MILLER VP, MEDICAL & QUALITY SERVICES 383243 0 119670 0 49426 0 25185 0 12470 0 589994 0 0 0 JULIE SMOLICH SVP, PROVIDER SERVICES 318615 0 122176 0 47239 0 25185 0 28821 0 542036 0 0 0 JAMIE MARGOLIS SVP, DONOR SERVICES 286750 0 109050 0 45609 0 25185 0 12611 0 479205 0 0 0 ERICA JENSEN SVP, REGISTRY GROWTH & DEVELOPMENT 280924 0 105570 0 34384 0 0 0 29361 0 450239 0 0 0 PATRICK REINKEN VP, LEGAL AFFAIRS & RISK MGMT/AGC 266562 0 82124 0 39646 0 25185 0 28554 0 442071 0 0 0 REBECCA JORGENSON SVP, INNOVATION - THRU 3/2020 75387 0 0 0 316423 0 0 0 3050 0 394860 0 0 0 GINA GRAVES ACT. CFO-THRU 4/21; VP FIN-THRU 8/21 198041 0 87331 0 24468 0 24870 0 15248 0 349958 0 0 0 INDIA HOOK-BARNARD SVP, PATIENT OUTCOME & EXP-THRU 4/20 87530 0 0 0 237008 0 0 0 6541 0 331079 0 0 0 DENNIS CONFER CMO EMERITUS - THRU 9/2021 104960 0 300 0 139 0 25185 0 6122 0 136706 0 0 0 PART I, LINE 1A: TAX INDEMNIFICATION & GROSS-UP PAYMENTS THE ORGANIZATION PROVIDED A RELOCATION STIPEND FOR INDIA HOOK-BARNARD. NMDP PROVIDED FOR TAX GROSS-UP OF THE RELOCATION AMOUNT. THE VALUE HAS BEEN INCLUDED IN HER W-2. PART I, LINE 4A-B: LINE 4A SEVERANCE PAYMENT THE FOLLOWING INDIVIDUALS LEFT NMDP DURING 2020 AND RECEIVED SEPARATION PAYMENTS DURING CALENDAR YEAR 2020. THE AMOUNTS HAVE BEEN INCLUDED IN SCHEDULE J, PART II, COLUMN B (III): C. RANDAL MILLS $591,667 REBECCA JORGENSON $290,000 INDIA HOOK-BERNARD $200,769 LINE 4B SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN THE ORGANIZATION OFFERS ITS OFFICERS, SENIOR VICE PRESIDENTS, VICE PRESIDENTS, AND DIRECTORS A 457(B) DEFERRED COMPENSATION PLAN (THE PLAN) CREATED IN ACCORDANCE WITH APPLICABLE PROVISIONS OF THE INTERNAL REVENUE CODE. THE PLAN PERMITS EMPLOYEES TO DEFER A PORTION OF THEIR SALARY UNTIL FUTURE YEARS. THE ACCUMULATED DEFERRED COMPENSATION BALANCE IS NOT AVAILABLE TO EMPLOYEES UNTIL TERMINATION, RETIREMENT, DEATH OR UNFORESEEABLE EMERGENCY. ALL AMOUNTS OF COMPENSATION DEFERRED UNDER THE PLAN, AND ALL INCOME ATTRIBUTABLE TO THOSE AMOUNTS, ARE (UNTIL PAID OR MADE AVAILABLE TO THE EMPLOYEE OR OTHER BENEFICIARY) SOLELY THE PROPERTY OF THE ORGANIZATION, AND THE ORGANIZATION HAS ALL THE RELATED RIGHTS OF OWNERSHIP (NOT RESTRICTED TO THE PAYMENT OF BENEFITS UNDER THE PLAN), SUBJECT ONLY TO THE CLAIM OF THE ORGANIZATION'S GENERAL CREDITORS. PARTICIPANTS' RIGHTS UNDER THE PLAN ARE EQUAL TO THOSE OF GENERAL CREDITORS OF THE ORGANIZATION IN AN AMOUNT EQUAL TO THE FAIR MARKET VALUE OF THE DEFERRED ACCOUNT FOR EACH PARTICIPANT. THE RELATED ASSETS AND LIABILITIES ARE REPORTED AT FAIR MARKET VALUE BASED ON QUOTED MARKET PRICES AND ARE INCLUDED WITHIN DEFERRED COMPENSATION FUNDS AND DEFERRED COMPENSATION PAYABLE IN THE CONSOLIDATED STATEMENTS OF FINANCIAL POSITION. THE ORGANIZATION OFFERS A SUPPLEMENTAL BENEFITS PLAN (THE SUPPLEMENTAL PLAN) FOR ITS OFFICERS, SENIOR VICE PRESIDENTS AND VICE PRESIDENTS. ALL SUPPLEMENTAL PLAN PARTICIPANTS RECEIVED LIFE INSURANCE, DISABILITY SALARY CONTINUATION, LONG-TERM DISABILITY AND LONG-TERM CARE INSURANCE. THE SUPPLEMENTAL PLAN WAS CREATED IN ACCORDANCE WITH APPLICABLE PROVISIONS OF THE INTERNAL REVENUE CODE (IRC SEC 7702) WHEREBY AFTER-TAX CONTRIBUTIONS INTO THE PLAN ACCUMULATE WITHOUT TAXATION AND MAY BE DISTRIBUTED WITHOUT TAXATION USING A COMBINATION OF TAX-FREE WITHDRAWALS AND LOANS. CONTRIBUTIONS WILL RESULT IN CURRENT INCOME TAXATION. PLAN BALANCES ARE PERSONALLY OWNED BY THE PLAN PARTICIPANTS IMMEDIATELY AND ARE NOT SUBJECT TO A RISK OF FORFEITURE; AS SUCH, THE PLAN ASSETS ARE NOT RECORDED ON THE ORGANIZATION'S FINANCIAL STATEMENTS. THE SUPPLEMENTAL PLAN ALSO PROVIDES FOR ADDITIONAL LIFE INSURANCE UP TO $750,000. EFFECTIVE OCTOBER 1, 2020, THE ORGANIZATION OFFERS A LONG-TERM INCENTIVE PLAN (LTIP) FOR ITS EXECUTIVES, REPLACING THE PREVIOUS GUARANTEED EXECUTIVE BENEFIT ALLOWANCE AND TIME OFF CONVERSION TO THE SUPPLEMENTAL 457(B) PLAN. THE LTIP IS A VARIABLE COMPENSATION PROGRAM THAT LINKS EXECUTIVE COMPENSATION TO ACHIEVEMENT OF LONG-TERM PERFORMANCE RESULTS AND STRATEGIC INITIATIVES. THE LTIP IS UNFUNDED AND PARTICIPANTS' ESTIMATED EARNINGS UNDER THE PROGRAM ARE RECORDED AS A LIABILITY WITHIN ACCRUED COMPENSATION AND BENEFITS FOR THE SHORT-TERM PORTION AND DEFERRED COMPENSATION PAYABLE FOR THE LONG TERM PORTION IN THE CONSOLIDATED STATEMENT OF FINANCIAL POSITION, UNTIL PAID OUT. PART I, LINE 7: EMPLOYEE INCENTIVE PLAN PAYMENTS EMPLOYEE ANNUAL INCENTIVE PLAN PAYMENTS ARE DETERMINED EACH YEAR AS PART OF THE PERFORMANCE EVALUATION COMPLETED BY HUMAN RESOURCES IN COLLABORATION WITH THE INDIVIDUAL'S MANAGER. THE ANNUAL INCENTIVE PLAN IS DETERMINED BY TAKING INTO ACCOUNT THE RESULTS OF THE ORGANIZATION'S OPERATING METRICS AND EACH DEPARTMENT'S GOALS. THE LTIP IS AN INCENTIVE PLAN THAT LINKS OFFICER'S, SENIOR VICE PRESIDENT'S AND VICE PRESIDENT'S COMPENSATION TO ACHIEVEMENT OF LONG-TERM PERFORMANCE RESULTS AND STRATEGIC INITIATIVES OVER A THREE-YEAR PERFORMANCE PERIOD. INITIAL AWARDS INCLUDED A TWO-YEAR PERFORMANCE PERIOD TO TRANSITION FROM THE PRIOR PROGRAM. LTIP AWARDS WILL BE CALCULATED USING THE BASE SALARY IN EFFECT ON THE LAST DAY OF THE PERFORMANCE PERIOD, MULTIPLIED BY THE LTIP TARGET PERCENTAGE ESTABLISHED AT THE BEGINNING OF EACH PERFORMANCE PERIOD, MULTIPLIED BY FINAL EXECUTIVE OPERATING PERFORMANCE INDEX ("EXECUTIVE OPI") RESULTS FOR THE PERFORMANCE PERIOD, SUBJECT TO ACHIEVING THRESHOLD PERFORMANCE REQUIREMENTS. X DONATED SAL. 1 264772 FMV 0 1 0 PART I, COLUMN (B): METHOD USED NMDP USES THE NUMBER OF DONATED SALARIES AS THE METHOD FOR DETERMINING THE AMOUNT IN COLUMN (B). FORM 990, PART III, LINE 1, ELABORATION OF MISSION STATEMENT: BE THE MATCH IS A GLOBAL LEADER WORKING EVERY DAY TO SAVE LIVES THROUGH CELLULAR THERAPY. FOR PEOPLE WITH LIFE-THREATENING BLOOD CANCERS - LIKE LEUKEMIA AND LYMPHOMA - OR OTHER BLOOD DISORDERS LIKE SICKLE CELL, A CURE EXISTS. BE THE MATCH CONNECTS PATIENTS WITH A MATCHING DONOR FOR A LIFE-SAVING BLOOD STEM CELL TRANSPLANT. THE BE THE MATCH REGISTRY IS THE MOST DIVERSE REGISTRY IN THE WORLD AND INCLUDES BOTH ADULT DONORS WILLING TO DONATE TO A STRANGER IN NEED AND STORED CORD BLOOD UNITS. IN ADDITION, BE THE MATCH PROVIDES PATIENTS AND THEIR FAMILIES ONE-ON-ONE SUPPORT, EDUCATION, AND GUIDANCE BEFORE, DURING AND AFTER TRANSPLANT. BE THE MATCH IS ALSO A GLOBAL LEADER IN RESEARCH THROUGH THE CIBMTR (CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH), A COLLABORATION WITH MEDICAL COLLEGE OF WISCONSIN, INVESTING IN AND MANAGING RESEARCH STUDIES THAT IMPROVE PATIENT OUTCOMES AND ADVANCE THE FUTURE OF CARE. THE BE THE MATCH FOUNDATION SUPPORTS PATIENTS BEFORE, DURING AND AFTER TRANSPLANT BY RAISING FUNDS TO: - ADD NEW POTENTIAL DONORS TO THE REGISTRY - HELP PAY UNINSURED PATIENT COSTS ASSOCIATED WITH TRANSPLANT - FUND LIFE-SAVING RESEARCH THROUGH THE CIBMTR. AS THE WORLD'S LEADING NONPROFIT ORGANIZATION FOCUSED ON SAVING LIVES THROUGH CELLULAR THERAPY, BE THE MATCH CONTINUES TO IMPROVE ACCESS TO TRANSPLANT BY LEADING EFFORTS TO REMOVE BARRIERS TO TREATMENT AND STRENGTHEN OUR ABILITY TO MEET THE GROWING NEED. THROUGH OUR GLOBAL NETWORK, WE CONNECT CENTERS AND PATIENTS TO BEST CELL THERAPY OPTION - FROM BLOOD STEM CELL TRANSPLANT TO A NEXT-GENERATION THERAPY - AND COLLABORATE WITH CELL AND GENE THERAPY COMPANIES TO SUPPORT THERAPY DEVELOPMENT AND DELIVERY THROUGH BE THE MATCH BIOTHERAPIES. THE DEFINITION FOR THE BE THE MATCH TRUE NORTH GOAL OF LIVES EQUALS THE NUMBER OF PATIENTS WHO RECEIVE BE THE MATCH-FACILITATED CELL THERAPIES. AS THE USE OF THERAPIES EXPANDS, SO HAS BE THE MATCH'S WORK IN UNRELATED AND RELATED DONOR TRANSPLANTS AND BIOTHERAPIES AUTOLOGOUS (DONATION FOR SELF), ALLOGENEIC (DONATION FOR NON-SPECIFIC PATIENT) AND CLINICAL TRIALS. THE VISION OF BE THE MATCH IS FOR EVERY PATIENT TO RECEIVE A TRANSPLANT NO MATTER THEIR ETHNIC BACKGROUND. EVERY YEAR, MORE PATIENTS ARE RECEIVING THE LIFE-SAVING MARROW OR CORD BLOOD TRANSPLANT THEY NEED BECAUSE OF THE COMMUNITY OF DONORS, VOLUNTEERS, HEALTH CARE PROFESSIONALS, RESEARCHERS AND FINANCIAL SUPPORTERS. FORM 990, PART VI, SECTION A, LINE 1 DELEGATION OF AUTHORITY THE NMDP BYLAWS STATE: "THE EXECUTIVE COMMITTEE SHALL AT ALL TIMES INCLUDE THE CHAIR OF THE BOARD, THE IMMEDIATE PAST CHAIR (WHEN IN OFFICE), THE CHAIR-ELECT (WHEN IN OFFICE), THE SECRETARY, THE CHIEF EXECUTIVE OFFICER, AND ANY GOVERNMENT REPRESENTATIVES. ANY AND ALL ADDITIONAL MEMBERS OF THE EXECUTIVE COMMITTEE SHALL BE VOTING DIRECTORS, EXCEPT THE CHIEF EXECUTIVE OFFICER AND GOVERNMENT REPRESENTATIVES, WHO SHALL SERVE AS NON-VOTING EX OFFICIO MEMBERS OF THE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL, TO THE EXTENT ALLOWED BY APPLICABLE LAW, HAVE THE AUTHORITY OF THE BOARD IN THE OVERSIGHT OF THE BUSINESS OF THE CORPORATION BETWEEN MEETINGS OF THE FULL BOARD AND SHALL HAVE SUCH OTHER AUTHORITY AND RESPONSIBILITIES AS SET FORTH IN THE EXECUTIVE COMMITTEE CHARTER." THE EXECUTIVE COMMITTEE CHARTER STATES: "THE EXECUTIVE COMMITTEE SHALL, TO THE EXTENT DETERMINED BY THE BOARD OF DIRECTORS, HAVE THE AUTHORITY OF THE BOARD IN THE OVERSIGHT OF THE BUSINESS OF THE CORPORATION BETWEEN MEETINGS OF THE FULL BOARD. THE EXECUTIVE COMMITTEE SHALL MANAGE THE BUSINESS OF THE CORPORATION AND DIRECT AND COORDINATE THE WORK ACTIVITIES OF COMMITTEES BETWEEN MEETINGS OF THE BOARD. THE EXECUTIVE COMMITTEE SHALL ALSO REVIEW KEY BOARD-LEVEL POLICIES AND PROCEDURES ON A PERIODIC BASIS AND RECOMMEND NEW OR MODIFIED POLICIES AND INITIATIVES. WITH THE BOARD, THE EXECUTIVE COMMITTEE IS RESPONSIBLE FOR OVERSIGHT OF THE STRATEGIC PLANNING PROCESS, DEVELOPING A CALENDAR FOR BOARD ACTIVITIES, AND PROVIDING GUIDANCE TO THE BOARD AND CORPORATION STAFF REGARDING THE APPROPRIATE ROLES OF EACH. THE EXECUTIVE COMMITTEE, IN CLOSE COORDINATION WITH THE FINANCE COMMITTEE, SHALL MONITOR THE FINANCIAL INTEGRITY OF OPERATIONS, INCLUDING EVALUATING PERFORMANCE AGAINST THE CORPORATION'S BUDGET AND STRATEGIC AND BUSINESS PLANS. IN ADDITION, THE EXECUTIVE COMMITTEE SHALL REPRESENT THE CORPORATION IN ITS INTERACTIONS WITH OTHER ORGANIZATIONS, CONGRESS, FEDERAL AGENCIES, PARTICIPATING CENTERS, CONSTITUENT GROUPS, PROFESSIONAL ORGANIZATIONS, AND THE PUBLIC." FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW PROCESS THE ORGANIZATION CONTRACTED WITH THE OUTSIDE PUBLIC ACCOUNTING FIRM, GRANT THORNTON LLP, TO PREPARE THE FORM 990. PREPARING THE DETAILS AND SUPPORTING REPORTS FOR THE RETURN IS A COLLABORATIVE EFFORT AMONG A SMALL GROUP OF INDIVIDUALS IN THE FINANCIAL REPORTING & COMPLIANCE AREA OF FINANCE, INTERNAL AUDIT AND HUMAN RESOURCES. THAT WORK IS THEN REVIEWED BY THE SENIOR MANAGER OF FINANCIAL REPORTING PRIOR TO SENDING TO GRANT THORNTON LLP; THE CHIEF LEGAL OFFICER ALSO REVIEWS THE GOVERNANCE SECTIONS PRIOR TO SENDING TO GRANT THORNTON LLP. ONCE A DRAFT IS RECEIVED BACK FROM GRANT THORNTON LLP, IT IS REVIEWED BY THE STAFF THAT PULLED THE DETAILS TOGETHER AND NMDP CHIEF FINANCIAL OFFICER. A COPY OF THE RETURN IS PROVIDED TO THE ORGANIZATION'S AUDIT AND FINANCE COMMITTEE AND BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY MONITORING & ENFORCEMENT THE CONFLICT OF INTEREST POLICY STATES THE FOLLOWING: "THE EXISTENCE OF AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST TURNS ON THE SPECIFIC FACTS AND CIRCUMSTANCES IN EACH CASE. IF A MEMBER HAS AN INTEREST WHICH MAY CONFLICT WITH THOSE OF THE ORGANIZATIONS, HE OR SHE MUST IMMEDIATELY DISCLOSE THE MATTERS AND DISCUSS THEM FULLY AND FRANKLY WITH THE APPLICABLE ORGANIZATION'S FULL BOARD OR ITS EXECUTIVE COMMITTEE, AS SET FORTH IN DETAIL BELOW. A MEMBER MUST NOT PARTICIPATE IN ANY MATTER IN WHICH THAT MEMBER MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST WITHOUT THE EXPRESS APPROVAL OF THE APPLICABLE ORGANIZATION'S BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS (EXECUTIVE COMMITTEE). ALL MEMBERS MUST DISCLOSE TO THE APPLICABLE ORGANIZATION'S BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE ALL CONFLICTS OF INTEREST AND REPORTABLE RELATIONSHIPS, AND MUST ANNUALLY COMPLETE AND SUBMIT THE CONFLICT OF INTEREST QUESTIONNAIRE WHICH IS REQUIRED BY THIS POLICY. WHENEVER IN THE COURSE OF EVENTS A MEMBER'S CIRCUMSTANCES CHANGE SUCH THAT THE MEMBER KNOWS OR HAS REASON TO BELIEVE THAT THE MEMBER MAY HAVE AN ACTUAL OR PERCEIVED CONFLICT OF INTEREST, SUCH MEMBER SHALL PROMPTLY DISCLOSE THE POTENTIAL CONFLICT TO THE APPLICABLE ORGANIZATION'S BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE. FOR THE PURPOSES OF THIS ARTICLE, A MEMBER MAY FORMALLY DISCLOSE A CONFLICT OR REPORTABLE RELATIONSHIP TO THE CHIEF EXECUTIVE OFFICER (CEO) OF NMDP, THE BTMF EXECUTIVE DIRECTOR AND SENIOR VICE PRESIDENT (SVP) OF PHILANTHROPY, OR THE NMDP CHIEF LEGAL OFFICER (CLO), AS APPLICABLE, WHO SHALL INFORM THE APPLICABLE ORGANIZATION'S BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE FOR RESOLUTION. AS NOTED HEREIN, IF THE POTENTIAL CONFLICT INVOLVES A DIRECTOR OR COMMITTEE MEMBER, THAT DIRECTOR OR COMMITTEE MEMBER SHALL NOT PARTICIPATE IN OR VOTE UPON SUCH MATTERS UNTIL THE QUESTION OF THE EXISTENCE OF THE CONFLICT OF INTEREST HAS BEEN RESOLVED IN ACCORDANCE WITH THIS POLICY. LIKEWISE, AN OFFICER OR KEY EMPLOYEE MAY NOT BECOME SUBSTANTIALLY INVOLVED IN DECISION-MAKING INVOLVING ANY COVERED LITIGATION, CONTRACT OR TRANSACTION UNTIL THE RESOLUTION OF THE MATTER IN ACCORDANCE WITH THIS POLICY." FORM 990, PART VI, SECTION B, LINE 15 PROCESS FOR DETERMINING COMPENSATION THE NMDP BYLAWS STATE: "THE COMPENSATION COMMITTEE SHALL BE COMPRISED ONLY OF VOTING DIRECTORS AND SHALL INCLUDE THE CHAIR OF THE BOARD AND AT LEAST ONE (1) NON-OFFICER BOARD MEMBER AS VOTING COMMITTEE MEMBERS. THE COMPENSATION COMMITTEE SHALL REVIEW AND EVALUATE THE OVERALL COMPENSATION AND BENEFIT STRUCTURE OF THE CORPORATION AND SHALL HAVE SUCH OTHER AUTHORITY AND RESPONSIBILITIES AS SET FORTH IN THE COMPENSATION COMMITTEE CHARTER." THE COMPENSATION COMMITTEE CHARTER STATES: "THE COMMITTEE SHALL REVIEW AND EVALUATE THE OVERALL COMPENSATION AND BENEFIT STRUCTURE OF THE CORPORATION, AND APPROVE AND ADOPT A COMPENSATION PHILOSOPHY AND PRINCIPLES CONSISTENT WITH THE CORPORATION'S NON-FOR-PROFIT STATUS (THE COMPENSATION PHILOSOPHY AND PRINCIPLES). THE COMMITTEE SHALL CONDUCT THE CHIEF EXECUTIVE OFFICER (CEO) PERFORMANCE EVALUATION. THE COMMITTEE SHALL MAKE CEO TOTAL COMPENSATION AND BENEFIT RECOMMENDATIONS TO THE EXECUTIVE COMMITTEE, CONSISTENT WITH THE COMPENSATION PHILOSOPHY AND PRINCIPLES. IN MAKING COMPENSATION AND BENEFIT RECOMMENDATIONS FOR THE CEO, THE COMMITTEE SHALL UTILIZE, AMONG OTHER THINGS, COMPARABILITY DATA FOR COMPLIANCE WITH IRS INTERMEDIATE SANCTION PROVISIONS SO AS TO ALLOW THE CORPORATION TO TAKE ADVANTAGE OF THE REBUTTABLE PRESUMPTION OF REASONABLENESS. ON A PERIODIC BASIS, THE COMMITTEE SHALL OBTAIN COMPARABILITY DATA FROM AN INDEPENDENT COMPENSATION CONSULTANT. IN ADDITION, THE COMMITTEE SHALL ADVISE THE CEO IN HIS/HER EVALUATION OF AND DECISIONS REGARDING THE COMPENSATION OF AND BENEFITS FOR SENIOR CORPORATION EMPLOYEES, AS WELL AS THE PRESIDENT (OR EQUIVALENT LEADER) OF ANY SUBSIDIARY OF THE CORPORATION REPORTING TO THE CEO (TOGETHER, SENIOR LEADERSHIP). IN ADVISING THE CEO IN MAKING HIS/HER COMPENSATION AND BENEFIT DECISIONS FOR SENIOR LEADERSHIP, THE COMMITTEE SHALL ENSURE THAT SUCH DECISIONS ARE CONSISTENT WITH THE COMPENSATION PHILOSOPHY AND PRINCIPLES, AND UTILIZE, AMONG OTHER THINGS, COMPARABILITY DATA FOR COMPLIANCE WITH IRS INTERMEDIATE SANCTION PROVISIONS. IF DECISIONS PROPOSED BY THE CEO ARE OUTSIDE THE PARAMETERS OF THE COMPENSATION PHILOSOPHY AND PRINCIPLES, THE CEO MUST OBTAIN THE COMMITTEE'S APPROVAL PRIOR TO IMPLEMENTATION." FORM 990, PART VI, SECTION C, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE CONFLICT OF INTEREST POLICY, ARTICLES OF INCORPORATION AND CONSOLIDATED AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. SUMMARY FINANCIAL STATEMENTS ARE ALSO INCLUDED IN OUR ANNUAL REPORT, WHICH IS MAILED TO KEY STAKEHOLDERS AND POSTED ON OUR WEBSITE. ADDITIONALLY, ARTICLES OF INCORPORATION ARE AVAILABLE THROUGH THE MN OFFICE OF THE SECRETARY OF STATE, AND CONSOLIDATED AUDITED FINANCIAL STATEMENTS MAY BE OBTAINED AT THE MN OFFICE OF THE ATTORNEY GENERAL. FORM 990, PART VII, SECTION A, LINE 1A, COLUMN B: HOURS FOR RELATED ORGANIZATION THE HOURS LISTED ON THE 990 PART VII ARE BASED ON A 50 HOUR WEEK THAT THESE INDIVIDUALS DEVOTED TO NMDP AND BTMF IN TOTAL DURING THE YEAR. FORM 990, PART VII, SECTION A, LINE 1A, COLUMN D: COMPENSATION NMDP PROVIDED REPORTABLE COMPENSATION TO DAVID PORTER FOR CONSULTING SERVICES PROVIDED AS CHAIR OF THE CIBMTR DATA SAFETY MONITORING BOARD MEETINGS DURING CALENDER YEAR 2020. BE THE MATCH COLLECTION SERVICES LLC 500 N 5TH ST MINNEAPOLIS MN 554011206 811241889 CELL THERAPY MN -2438771 3537580 NMDP BE THE MATCH FOUNDATION 500 N 5TH STREET MINNEAPOLIS MN 554011206 411704734 FUNDRAISING MN 501(C)(3) LINE 7 NMDP 1 BE THE MATCH MX AC VERACRUZ AV 93 101 PISO CUIDAD DE MEXICO CONDESA MX 06140 RECRUITMENT MX NMDP 1 CLEAR INSURANCE LTD (FORMERLY CLR) 62 FORUM LN 3RD FL PO BOX 30600 CJ KY1-1203 840865803 CAPTIVE INSURANCE CJ NMDP C 83824 5019075 1.00000 1 BE THE MATCH AUXILIARY SERVICES LLC (FORMERLY BTMBTS) 500 N 5TH STREET MINNEAPOLIS MN 554011206 811248190 CELL THERAPY MN NMDP C -364293 615626 1.00000 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 1 0 1 1 0 BE THE MATCH AUXILIARY SERVICES LLC (FORMERLY BTMBTS) A 317701 FMV BE THE MATCH FOUNDATION B 7715917 COST BE THE MATCH AUXILIARY SERVICES LLC (FORMERLY BTMBTS) B 600000 COST BE THE MATCH MEXICO B 2764042 COST BE THE MATCH FOUNDATION C 2524739 COST BE THE MATCH FOUNDATION N 148579 COST BE THE MATCH FOUNDATION O 1116000 COST BE THE MATCH MEXICO O 895000 COST BE THE MATCH MEXICO Q 1075652 COST CLEAR INSURANCE LTD (FORMERLY CLR) R 2093380 COST